{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:43:17Z","timestamp":1791301397033,"version":"4.1.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    This report described a male patient presenting with recurrent fever, fatigue, persistent abdominal distension, and diarrhea, who was repeatedly misdiagnosed with decompensated cirrhosis at multiple hospitals. The diagnostic process was complex, ultimately leading to the diagnosis of TAFRO syndrome through lymph node and bone marrow biopsies, following\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT imaging. The patient initially responded to treatment, while later succumbed to severe intra-abdominal infection and multiple organ failure. TAFRO syndrome, a rare subtype of Castleman disease, is frequently misdiagnosed due to limited clinical awareness, delaying appropriate treatment. This case highlighted the diagnostic challenges and therapeutic considerations associated with TAFRO syndrome, providing insights for clinical practice based on the existing research.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1554198","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:10:33Z","timestamp":1743639033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case Report: TAFRO syndrome misdiagnosed as liver cirrhosis due to persistent abdominal distension"],"prefix":"10.3389","volume":"16","author":[{"given":"Luyuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzhuo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-1979-1","article-title":"Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version","volume":"103","author":"Masaki","year":"2016","journal-title":"Int J Hematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27612","article-title":"Exploring the clinical diversity of castleman disease and TAFRO syndrome: A Japanese multicenter study on lymph node distribution patterns","volume":"100","author":"Otsuka","year":"2025","journal-title":"Am J Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i5.1536","article-title":"Castleman disease and TAFRO syndrome: To improve the diagnostic consciousness is the key","volume":"10","author":"Zhou","year":"2022","journal-title":"World J Clin Cases"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2017.1930","article-title":"TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease","volume":"17","author":"Srkalovic","year":"2017","journal-title":"Bosn. J Basic Med Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/hon.2969","article-title":"Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review","volume":"40","author":"Belyaeva","year":"2022","journal-title":"Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2018.12.025","article-title":"An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome","volume":"215","author":"Kurose","year":"2019","journal-title":"Pathol Res Pract"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04762-6","article-title":"Castleman disease and TAFRO syndrome","volume":"101","author":"Masaki","year":"2022","journal-title":"Ann Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3075","article-title":"TAFRO syndrome: A disease that known is half cured","volume":"41","author":"Chen","year":"2023","journal-title":"Hematol Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i9.1656","article-title":"Liver cirrhosis in a child associated with Castleman\u2019s disease: A case report","volume":"8","author":"Kobayashi","year":"2020","journal-title":"World J Clin Cases"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e01446","DOI":"10.14309\/crj.0000000000001446","article-title":"Idiopathic multicentric castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis\/renal insufficiency, and organomegaly (TAFRO) syndrome in a liver transplant recipient","volume":"11","author":"Mashal","year":"2024","journal-title":"ACG Case Rep J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s12882-020-02191-z","article-title":"Idiopathic multicentric Castleman disease with Sj\u00f6gren\u2019s syndrome and secondary membranous nephropathy: a case report and review of the literature","volume":"21","author":"Pan","year":"2020","journal-title":"BMC Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae110","article-title":"Long-term clinicopathological characteristics of TAFRO syndrome and its relapse: a case series study","volume":"17","author":"Yoshimura","year":"2024","journal-title":"Clin Kidney J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1178-22","article-title":"Severe TAFRO syndrome mimicking hepatorenal syndrome successfully treated with a multidisciplinary approach: A case report and literature review","volume":"62","author":"Yamamoto","year":"2023","journal-title":"Intern Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12882-019-1574-9","article-title":"TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review","volume":"20","author":"Nagayama","year":"2019","journal-title":"BMC Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.3390\/ijms22126286","article-title":"TAFRO syndrome with renal thrombotic microangiopathy: insights into the molecular mechanism and treatment opportunities","volume":"22","author":"Tu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1266187","article-title":"Case Report: A case of TAFRO syndrome with severe and prolonged thrombocytopenia: diagnostic pitfalls","volume":"14","author":"Sato","year":"2023","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3390\/biomedicines12061277","article-title":"TAFRO syndrome: guidance for managing patients presenting thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly","volume":"12","author":"Miura","year":"2024","journal-title":"Biomedicines"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-545087","article-title":"HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy","volume":"123","author":"Fajgenbaum","year":"2014","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/biomedicines12061141","article-title":"Biomarkers and signaling pathways implicated in the pathogenesis of idiopathic multicentric castleman disease\/thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly (TAFRO) syndrome","volume":"12","author":"Sumiyoshi","year":"2024","journal-title":"Biomedicines"},{"key":"B20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3960\/jslrt.22010","article-title":"Candidate biomarkers for idiopathic multicentric Castleman disease","volume":"62","author":"Sumiyoshi","year":"2022","journal-title":"J Clin Exp Hematop"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103137","article-title":"TAFRO syndrome: A severe manifestation of Sjogren\u2019s syndrome? A systematic review","volume":"21","author":"Grange","year":"2022","journal-title":"Autoimmun. Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1554198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:10:35Z","timestamp":1743639035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1554198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2025.1554198"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1554198","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"article-number":"1554198"}}